中國核學會成立于1980年，是在“兩彈一星”功勛科學家倡議發起，具有法人資格的全國性、學術性、非營利性的社會團體，是中國科學技術協會的重要組成部分（同年加入），接受民政部的監督管理。倡導獻身、創新、求實、協作的精神，旨在促進核科學技術的普及和推廣、繁榮和發展。
近距離治療、放療手術機器人以及人工智能/放療云技術是近年來放療應用發展最為快速的領域之一。在中國核學會以及各學科專家學者的倡導與支持下，以北京大學第三醫院為依托單位，經過組織專家論證，順利通過中國核學會評估答辯，并正式批準成立“近距離治療與智慧放療分會”。
經過積極的準備工作，分會于2019年9月19日在北京成功舉辦線上+線下成立大會，并通過選舉產生第一屆理事會組織架構，標志著分會正式開始運行。
分會將在中國核學會的領導和支持下，致力于實現以學術為導向，核技術應用為目標，先進放療技術產品/解決方案為引擎，臨床應用實踐為核心價值，基于人工智能、大數據、云計算及互聯網技術，搭建創新應用服務平臺，營造從基層到高端醫療機構的全產業生態鏈，成為備受尊重的行業引領者。
Founded in 1980, Chinese Nuclear Society (CNS), affiliated the China Association of Science & Technology (CAST), is a national, academic and non-profit social organization with legal personality initiated by the "Two Bombs & One Star" meritorious scientists. It is a key part of the CAST and under the supervision and administration of the Ministry of Civil Affairs.
Brachytherapy, Robotic Radiosurgery and Artificial Intelligence plus cloud-based technology are one of the most rapidly developing areas of clinical application in recent years. With the support and advocacy of CNS and KOLs in radiotherapy nationwide, the 3th Hospital of Peking University initiates this sector, successfully elected and approved through the criteria of CNS, decided to set up "Brachytherapy & Intelligent Radiosurgery Division (BIRD) ".
19th Sep, 2020, Organized by CNS, BIRD founding conference held in Beijing successfully by Online plus Off-line after enough preparation. During the meeting, the First Board of Management Organization was elected, this marked BIRD kick-off operation formally as a historic milestone.
Under the leadership and support of the CNS, the BIRD will be aiming to implement by App-oriented with the clinical practicality of advanced nuclear/radiotherapy technologies and products, establish an ecological radiotherapy platform focusing on application, innovation, education and research, create core value and drive from basic to high-end users, resulted as a highly respected leader in Radiotherapy Industry worldwide.